Pharmaceutical packaging is basically packaging products, which are made using well-suited materials, for transfer & storage of the drug. In terms of nature of the drug, packaging products are selected from various material types & product types, to provide identification, protection, and ensure the integrity of enclosed drug product. Pharmaceutical drugs required to be protected from the various hazards that include chemical, biological, mechanical and climate. Pharmaceutical packaging is made using a variety of raw materials like paper & paperboards, glass, plastics, and metal, among others, in different drug-delivery modes for instance oral, transdermal, topical, pulmonary, injectable, nasal, interventional, and ocular. The increasing infiltration of retail pharmacies in emerging regions combined with an increasing focus on brand enrichment and product discrimination by pharmaceutical companies are the factors that are expected to drive the expansion of the pharmaceutical packaging market.
As per analysis, North America Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Country: Trend Outlook and Growth Opportunity. Few of the key companies that are presently operating in the North-America pharmaceutical packaging market include Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Catalent, Inc., Amcor PLC, Berry North America Group, Inc., Schott AG, Gerresheimer AG, WestRock Company, Catalent, Inc., AptarGroup, Inc., Berry North America Group, Inc., Amcor PLC, O-I Glass, Inc. (Owens Illinois, Inc.) and among others. Major players are focusing on the use of sustainable packaging materials due to growing concerns over the generation of hard-to-degrade packaging waste. Bioplastic is likely to gain importance in the market because they are made from the renewable plant-based sources and is environmental unlike the plastics & polymers derived from the fossil fuels. Pharmaceutical companies are expected to favor blister packs for tablets & capsules as they are more sustainable when compared to rigid bottles with minimal packaging material consumption. Additionally, the transparency of the blister packaging ensures a clear product presentation and offers tamper-proof properties.
Growth in healthcare spending, followed by increase in per-capita income, ban on counterfeit packaging products, growth in geriatric population and increase in health-conscious people are few major factors, which are accountable for growth of the North-America pharmaceutical packaging market. However, strict government regulations & standards is a key hindering factor for market.
Based on regional analysis, the North-America pharmaceutical packaging market is mainly driven by growth in contribution of nanotechnology advancement in manufacturing processes & technological innovation coupled with surge in demand for drug delivery devices & blister packaging. U.S will continue to be the prevalent national pharmaceutical packaging market in the future as the advanced drug manufacturing sector commercializes new sophisticated therapies with dedicated packaging needs. It is predicted that future of the North-America pharmaceutical packaging market will be optimistic because of advanced manufacturing processes to develop sustainable & eco-friendly packaging solutions, ban on counterfeit packaging products and growth in implementation of new regulations by governments to control the spread of infectious diseases during the forecast period.
For More Information, click on the link below:-
Europe Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Country: Trend Outlook and Growth Opportunity
Ankur Gupta, Head Marketing & Communications